A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Jacek Hajda, Monika Lehmann, Ottheinz Krebs, Meinhard Kieser, Karsten Geletneky, Dirk Jäger, Michael Dahm, Bernard Huber, Tilman Schöning, Oliver Sedlaczek, Albrecht Stenzinger, Niels Halama, Volker Daniel, Barbara Leuchs, Assia Angelova, Jean Rommelaere, Christine E. Engeland, Christoph Springfeld, Guy Ungerechts

ABSTRACT

BACKGROUND: Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month progression-free survival of approximately 50% and a median survival of about 11 months. Despite intensive research, only slight improvements of clinical outcome could be achieved over the last decades. Hence, new and innovative therapeutic strategies are urgently required. ParvOryx is a drug product containing native parvovirus H-1 (H-1PV). Since H-1PV was shown to exert pronounced anti-neoplastic effects in pre-clinical models of pancreatic cancer, the drug appears to be a promising candidate for treatment of this malignancy. METHODS: ParvOryx02 is a non-controlled, single arm, open label, dose-escalating, single center trial. In total seven patients with pancreatic cancer showing at least one hepatic metastasis are to be treated with escalating doses of ParvOryx according to the following schedule: i) 40% of the total dose infused intravenously in equal fractions on four consecutive days, ii) 60% of the total dose injected on a single occasion directly into the hepatic metastasis at varying intervals after intravenous infusions. The main eligibility criteria are: age ≥ 18 years, disease progression despite first-line chemotherapy, and at least one hepatic metastasis. Since it is the second trial within the drug development program, the study primarily explores safety and tolerability after further dose escalation of ParvOryx. The secondary objectives are related to the evaluation of certain aspects of anti-tumor activity and clinical efficacy of the drug. DISCUSSION: This trial strongly contributes to the clinical development program of ParvOryx. The individual hazards for patients included in the current study and the environmental risks are addressed and counteracted adequately. Besides information on safety and tolerability of the treatment after further dose escalation, thorough evaluations of pharmacokinetics and intratumoral spread as well as proof-of-concept (PoC) in pancreatic cancer will be gained in the course of the trial. TRIAL REGISTRATION: ClinicalTrials.gov-ID: NCT02653313 , Registration date: Dec. 4th, 2015. More... »

PAGES

576

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-017-3604-y

DOI

http://dx.doi.org/10.1186/s12885-017-3604-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091370822

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28851316


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "H-1 parvovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intralesional", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Virotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Viruses", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sample Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Coordination Centre for Clinical Trials, University Hospital Heidelberg, Marsilius-Arkaden, Tower West, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hajda", 
        "givenName": "Jacek", 
        "id": "sg:person.0605770352.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605770352.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Coordination Centre for Clinical Trials, University Hospital Heidelberg, Marsilius-Arkaden, Tower West, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmann", 
        "givenName": "Monika", 
        "id": "sg:person.01130362500.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130362500.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ORYX (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.476663.6", 
          "name": [
            "Oryx GmbH & Co KG, Marktplatz 1, 85598, Baldham, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krebs", 
        "givenName": "Ottheinz", 
        "id": "sg:person.011060761054.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060761054.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Institute of Medical Biometry and Informatics, University Hospital Heidelberg, Marsilius-Arkaden, Tower West, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kieser", 
        "givenName": "Meinhard", 
        "id": "sg:person.01100645057.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100645057.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinikum Darmstadt", 
          "id": "https://www.grid.ac/institutes/grid.419810.5", 
          "name": [
            "Department of Neurosurgery, Klinikum Darmstadt, Grafenstra\u00dfe 9, 64283, Darmstadt, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Geletneky", 
        "givenName": "Karsten", 
        "id": "sg:person.0644466327.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644466327.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Medical Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "J\u00e4ger", 
        "givenName": "Dirk", 
        "id": "sg:person.0726633256.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726633256.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ORYX (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.476663.6", 
          "name": [
            "Oryx GmbH & Co KG, Marktplatz 1, 85598, Baldham, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dahm", 
        "givenName": "Michael", 
        "id": "sg:person.01147032652.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147032652.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ORYX (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.476663.6", 
          "name": [
            "Oryx GmbH & Co KG, Marktplatz 1, 85598, Baldham, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huber", 
        "givenName": "Bernard", 
        "id": "sg:person.0642002247.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642002247.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Central Pharmacy, University Hospital Heidelberg, Im Neuenheimer Feld 670, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sch\u00f6ning", 
        "givenName": "Tilman", 
        "id": "sg:person.01143116022.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143116022.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Radiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sedlaczek", 
        "givenName": "Oliver", 
        "id": "sg:person.01057707502.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057707502.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stenzinger", 
        "givenName": "Albrecht", 
        "id": "sg:person.0642700650.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642700650.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tissue Imaging & Analysis Center (TIGA), University Heidelberg \u2013 BioQuant, Im Neuenheimer Feld 267, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halama", 
        "givenName": "Niels", 
        "id": "sg:person.01040326116.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040326116.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Institute of Immunology, Transplantation Immunology, University Hospital Heidelberg, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daniel", 
        "givenName": "Volker", 
        "id": "sg:person.01240304374.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240304374.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Applied Tumor Virology, German Cancer Research Center, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leuchs", 
        "givenName": "Barbara", 
        "id": "sg:person.01145603317.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145603317.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Applied Tumor Virology, German Cancer Research Center, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Angelova", 
        "givenName": "Assia", 
        "id": "sg:person.01257757651.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257757651.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Applied Tumor Virology, German Cancer Research Center, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rommelaere", 
        "givenName": "Jean", 
        "id": "sg:person.01061037342.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061037342.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Medical Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Engeland", 
        "givenName": "Christine E.", 
        "id": "sg:person.0704340157.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704340157.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Medical Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Springfeld", 
        "givenName": "Christoph", 
        "id": "sg:person.0735442654.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735442654.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Medical Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ungerechts", 
        "givenName": "Guy", 
        "id": "sg:person.01030427112.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030427112.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2009.25.7550", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000628191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22852", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009856216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2015.328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010315581", 
          "https://doi.org/10.1038/bjc.2015.328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.03688-13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016708328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/mt.2014.194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018359073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0166-0934(91)90024-t", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021418357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0166-0934(91)90024-t", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021418357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1011923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022967950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-12-99", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031811534", 
          "https://doi.org/10.1186/1471-2407-12-99"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2014.10.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032696037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymthe.2004.07.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033281430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-1088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034525025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1304369", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034846582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-11-0242", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035264688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2012.12.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036026674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/mt.2008.29", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037260104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.gassur.2005.06.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037816799", 
          "https://doi.org/10.1016/j.gassur.2005.06.024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4471-6458-6_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039666242", 
          "https://doi.org/10.1007/978-1-4471-6458-6_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1439-0450.2005.00877.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044102158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1439-0450.2005.00877.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044102158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cgt.2010.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045602992", 
          "https://doi.org/10.1038/cgt.2010.65"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(14)61396-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046101168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046778815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/2162402x.2015.1115641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047118395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-5-60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049027309", 
          "https://doi.org/10.1186/1479-5876-5-60"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-14-2533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053419719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.145.3631.510", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062483166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.27.4.901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071515841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075234158", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076431462", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6092/1590-8577/2028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078811321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078931140", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079004265", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/76.6.1177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079761076"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month progression-free survival of approximately 50% and a median survival of about 11\u00a0months. Despite intensive research, only slight improvements of clinical outcome could be achieved over the last decades. Hence, new and innovative therapeutic strategies are urgently required. ParvOryx is a drug product containing native parvovirus H-1 (H-1PV). Since H-1PV was shown to exert pronounced anti-neoplastic effects in pre-clinical models of pancreatic cancer, the drug appears to be a promising candidate for treatment of this malignancy.\nMETHODS: ParvOryx02 is a non-controlled, single arm, open label, dose-escalating, single center trial. In total seven patients with pancreatic cancer showing at least one hepatic metastasis are to be treated with escalating doses of ParvOryx according to the following schedule: i) 40% of the total dose infused intravenously in equal fractions on four consecutive days, ii) 60% of the total dose injected on a single occasion directly into the hepatic metastasis at varying intervals after intravenous infusions. The main eligibility criteria are: age\u00a0\u2265\u00a018\u00a0years, disease progression despite first-line chemotherapy, and at least one hepatic metastasis. Since it is the second trial within the drug development program, the study primarily explores safety and tolerability after further dose escalation of ParvOryx. The secondary objectives are related to the evaluation of certain aspects of anti-tumor activity and clinical efficacy of the drug.\nDISCUSSION: This trial strongly contributes to the clinical development program of ParvOryx. The individual hazards for patients included in the current study and the environmental risks are addressed and counteracted adequately. Besides information on safety and tolerability of the treatment after further dose escalation, thorough evaluations of pharmacokinetics and intratumoral spread as well as proof-of-concept (PoC) in pancreatic cancer will be gained in the course of the trial.\nTRIAL REGISTRATION: ClinicalTrials.gov-ID: NCT02653313 , Registration date: Dec. 4th, 2015.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-017-3604-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol", 
    "pagination": "576", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7e76cf11567f170751ba399f290d4bcf057e07331408e97c7d84ecb87a50dc87"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28851316"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-017-3604-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091370822"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-017-3604-y", 
      "https://app.dimensions.ai/details/publication/pub.1091370822"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000493.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186/s12885-017-3604-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3604-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3604-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3604-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3604-y'


 

This table displays all metadata directly associated to this object as RDF triples.

366 TRIPLES      21 PREDICATES      75 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-017-3604-y schema:about N080ea5c662174bc9bcd85e19b1f9031e
2 N1e38159688a2482aa224a9b7b7240da0
3 N3704fd73ea0f40d5b5c643b2262d5e7c
4 N4027b18f9d184e10b9ed66cd3c52f2d0
5 N46ec53a6b2844dd2880019e0654baf9d
6 N4b3c5e732cba40659592f5ce1d16a5f9
7 N54ababb1512d48a3ab28f45cabdf5cec
8 N607456921fac4bf8b0494efa59a08737
9 N60a08c106d6440ca8d704db89f332647
10 N78afe738fc74408b8e2a1f236fad884f
11 Nacbeb08715e746ab9298d49095bc6693
12 Nc9ade8a8e971462cb411b2471914ac7c
13 Ne496d5ec363e4b1ebd103bf4087615be
14 Nf1a380fa1e0343499da78aa7315e7282
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nfc787c5484b146f2aa45ee792b6c0aae
18 schema:citation sg:pub.10.1007/978-1-4471-6458-6_5
19 sg:pub.10.1016/j.gassur.2005.06.024
20 sg:pub.10.1038/bjc.2015.328
21 sg:pub.10.1038/cgt.2010.65
22 sg:pub.10.1186/1471-2407-12-99
23 sg:pub.10.1186/1479-5876-5-60
24 https://app.dimensions.ai/details/publication/pub.1075234158
25 https://app.dimensions.ai/details/publication/pub.1076431462
26 https://app.dimensions.ai/details/publication/pub.1078931140
27 https://app.dimensions.ai/details/publication/pub.1079004265
28 https://doi.org/10.1002/cncr.22852
29 https://doi.org/10.1016/0166-0934(91)90024-t
30 https://doi.org/10.1016/j.canlet.2014.10.046
31 https://doi.org/10.1016/j.ejca.2012.12.027
32 https://doi.org/10.1016/j.ymthe.2004.07.021
33 https://doi.org/10.1016/s0140-6736(14)61396-9
34 https://doi.org/10.1038/mt.2008.29
35 https://doi.org/10.1038/mt.2014.194
36 https://doi.org/10.1056/nejmoa1011923
37 https://doi.org/10.1056/nejmoa1304369
38 https://doi.org/10.1080/2162402x.2015.1115641
39 https://doi.org/10.1093/annonc/mdu138
40 https://doi.org/10.1093/jnci/76.6.1177
41 https://doi.org/10.1111/j.1439-0450.2005.00877.x
42 https://doi.org/10.1126/science.145.3631.510
43 https://doi.org/10.1128/jvi.03688-13
44 https://doi.org/10.1158/0008-5472.can-14-2533
45 https://doi.org/10.1158/1078-0432.ccr-08-1088
46 https://doi.org/10.1158/2159-8290.cd-11-0242
47 https://doi.org/10.1200/jco.2009.25.7550
48 https://doi.org/10.3892/ijo.27.4.901
49 https://doi.org/10.6092/1590-8577/2028
50 schema:datePublished 2017-12
51 schema:datePublishedReg 2017-12-01
52 schema:description BACKGROUND: Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month progression-free survival of approximately 50% and a median survival of about 11 months. Despite intensive research, only slight improvements of clinical outcome could be achieved over the last decades. Hence, new and innovative therapeutic strategies are urgently required. ParvOryx is a drug product containing native parvovirus H-1 (H-1PV). Since H-1PV was shown to exert pronounced anti-neoplastic effects in pre-clinical models of pancreatic cancer, the drug appears to be a promising candidate for treatment of this malignancy. METHODS: ParvOryx02 is a non-controlled, single arm, open label, dose-escalating, single center trial. In total seven patients with pancreatic cancer showing at least one hepatic metastasis are to be treated with escalating doses of ParvOryx according to the following schedule: i) 40% of the total dose infused intravenously in equal fractions on four consecutive days, ii) 60% of the total dose injected on a single occasion directly into the hepatic metastasis at varying intervals after intravenous infusions. The main eligibility criteria are: age ≥ 18 years, disease progression despite first-line chemotherapy, and at least one hepatic metastasis. Since it is the second trial within the drug development program, the study primarily explores safety and tolerability after further dose escalation of ParvOryx. The secondary objectives are related to the evaluation of certain aspects of anti-tumor activity and clinical efficacy of the drug. DISCUSSION: This trial strongly contributes to the clinical development program of ParvOryx. The individual hazards for patients included in the current study and the environmental risks are addressed and counteracted adequately. Besides information on safety and tolerability of the treatment after further dose escalation, thorough evaluations of pharmacokinetics and intratumoral spread as well as proof-of-concept (PoC) in pancreatic cancer will be gained in the course of the trial. TRIAL REGISTRATION: ClinicalTrials.gov-ID: NCT02653313 , Registration date: Dec. 4th, 2015.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N0506df6b35124f5aab1989ea9637feef
57 Nf68e1f4c7b1c4301aaaa6e69e2b0b15d
58 sg:journal.1024632
59 schema:name A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
60 schema:pagination 576
61 schema:productId N071943b66aac45b38c04300842c2ec70
62 N2e2cc6b1a5fb4bbdb4a52fca00ebb7c9
63 N8105669f94f446b6bea9dd6b7e9e710e
64 Na520391ae80244a0ba97843d97557f24
65 Ncb3e59147c704e7aac3d757212c98411
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091370822
67 https://doi.org/10.1186/s12885-017-3604-y
68 schema:sdDatePublished 2019-04-11T00:12
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N654419973bec40fe8a6cb49baf3aa1e5
71 schema:url http://link.springer.com/10.1186/s12885-017-3604-y
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N00c1f69fcb1c49d0a80bab19070e1995 rdf:first sg:person.0642700650.98
76 rdf:rest N9f9e1ac446794a0487297a64f4a1c17c
77 N0506df6b35124f5aab1989ea9637feef schema:volumeNumber 17
78 rdf:type schema:PublicationVolume
79 N062d01ddbe0245ca9c1c4de387930617 rdf:first sg:person.0644466327.44
80 rdf:rest N63434497de4e422ca293f2a28ed0934f
81 N071943b66aac45b38c04300842c2ec70 schema:name nlm_unique_id
82 schema:value 100967800
83 rdf:type schema:PropertyValue
84 N080ea5c662174bc9bcd85e19b1f9031e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Pancreatic Neoplasms
86 rdf:type schema:DefinedTerm
87 N1484249b67154b53a6d73b75be531a99 schema:name Institute of Immunology, Transplantation Immunology, University Hospital Heidelberg, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany
88 rdf:type schema:Organization
89 N14ab5246454548829835ce3a497e886f rdf:first sg:person.011060761054.89
90 rdf:rest Nc53c076a4f8b42e087e7aabc0aa45c33
91 N1e38159688a2482aa224a9b7b7240da0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Injections, Intralesional
93 rdf:type schema:DefinedTerm
94 N2e2cc6b1a5fb4bbdb4a52fca00ebb7c9 schema:name pubmed_id
95 schema:value 28851316
96 rdf:type schema:PropertyValue
97 N3704fd73ea0f40d5b5c643b2262d5e7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name H-1 parvovirus
99 rdf:type schema:DefinedTerm
100 N3f122006c2384dcbb8c5eca4cdf458c6 rdf:first sg:person.01257757651.52
101 rdf:rest Nad979580ba7f4825a4cadced8793005a
102 N4027b18f9d184e10b9ed66cd3c52f2d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Administration, Intravenous
104 rdf:type schema:DefinedTerm
105 N43b7f6c4267947f6aeef2e847401a6af rdf:first sg:person.0642002247.65
106 rdf:rest N55fd48bfe8744718bb93c5ee139857a5
107 N46ec53a6b2844dd2880019e0654baf9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Survival Analysis
109 rdf:type schema:DefinedTerm
110 N4b3c5e732cba40659592f5ce1d16a5f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Male
112 rdf:type schema:DefinedTerm
113 N54ababb1512d48a3ab28f45cabdf5cec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Dose-Response Relationship, Drug
115 rdf:type schema:DefinedTerm
116 N55fd48bfe8744718bb93c5ee139857a5 rdf:first sg:person.01143116022.75
117 rdf:rest N71d2c1f3e437439a949cfa980b8aa7b7
118 N588b26f6ee1e47129539ee9316987bb2 schema:name Tissue Imaging & Analysis Center (TIGA), University Heidelberg – BioQuant, Im Neuenheimer Feld 267, 69120, Heidelberg, Germany
119 rdf:type schema:Organization
120 N607456921fac4bf8b0494efa59a08737 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Oncolytic Virotherapy
122 rdf:type schema:DefinedTerm
123 N60a08c106d6440ca8d704db89f332647 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Neoplasm Metastasis
125 rdf:type schema:DefinedTerm
126 N63434497de4e422ca293f2a28ed0934f rdf:first sg:person.0726633256.58
127 rdf:rest N9aaf9425331f4c91b6858526f5251755
128 N654419973bec40fe8a6cb49baf3aa1e5 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N664489fd76f746ac844b85201b49a5bb rdf:first sg:person.01145603317.47
131 rdf:rest N3f122006c2384dcbb8c5eca4cdf458c6
132 N71d2c1f3e437439a949cfa980b8aa7b7 rdf:first sg:person.01057707502.40
133 rdf:rest N00c1f69fcb1c49d0a80bab19070e1995
134 N78afe738fc74408b8e2a1f236fad884f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Treatment Outcome
136 rdf:type schema:DefinedTerm
137 N8105669f94f446b6bea9dd6b7e9e710e schema:name doi
138 schema:value 10.1186/s12885-017-3604-y
139 rdf:type schema:PropertyValue
140 N8c6bf9aacb434325bca4dbe232d55437 rdf:first sg:person.01030427112.43
141 rdf:rest rdf:nil
142 N9aaf9425331f4c91b6858526f5251755 rdf:first sg:person.01147032652.28
143 rdf:rest N43b7f6c4267947f6aeef2e847401a6af
144 N9f9e1ac446794a0487297a64f4a1c17c rdf:first sg:person.01040326116.86
145 rdf:rest Nd4f87abdbd1c4fd085184ca583070dd5
146 Na520391ae80244a0ba97843d97557f24 schema:name dimensions_id
147 schema:value pub.1091370822
148 rdf:type schema:PropertyValue
149 Na6da79d5144141fc947b8005cf3dc9e3 rdf:first sg:person.0704340157.73
150 rdf:rest Nb87e7f811518496088fbd24969b54913
151 Nacbeb08715e746ab9298d49095bc6693 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 Nad979580ba7f4825a4cadced8793005a rdf:first sg:person.01061037342.51
155 rdf:rest Na6da79d5144141fc947b8005cf3dc9e3
156 Nb87e7f811518496088fbd24969b54913 rdf:first sg:person.0735442654.05
157 rdf:rest N8c6bf9aacb434325bca4dbe232d55437
158 Nc53c076a4f8b42e087e7aabc0aa45c33 rdf:first sg:person.01100645057.61
159 rdf:rest N062d01ddbe0245ca9c1c4de387930617
160 Nc9ade8a8e971462cb411b2471914ac7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Sample Size
162 rdf:type schema:DefinedTerm
163 Nc9b1be90dbd74641a4e30e9d75cd9254 rdf:first sg:person.01130362500.35
164 rdf:rest N14ab5246454548829835ce3a497e886f
165 Ncb3e59147c704e7aac3d757212c98411 schema:name readcube_id
166 schema:value 7e76cf11567f170751ba399f290d4bcf057e07331408e97c7d84ecb87a50dc87
167 rdf:type schema:PropertyValue
168 Nd4f87abdbd1c4fd085184ca583070dd5 rdf:first sg:person.01240304374.43
169 rdf:rest N664489fd76f746ac844b85201b49a5bb
170 Ne496d5ec363e4b1ebd103bf4087615be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Oncolytic Viruses
172 rdf:type schema:DefinedTerm
173 Nf1a380fa1e0343499da78aa7315e7282 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Female
175 rdf:type schema:DefinedTerm
176 Nf68e1f4c7b1c4301aaaa6e69e2b0b15d schema:issueNumber 1
177 rdf:type schema:PublicationIssue
178 Nfc787c5484b146f2aa45ee792b6c0aae rdf:first sg:person.0605770352.37
179 rdf:rest Nc9b1be90dbd74641a4e30e9d75cd9254
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
184 schema:name Oncology and Carcinogenesis
185 rdf:type schema:DefinedTerm
186 sg:journal.1024632 schema:issn 1471-2407
187 schema:name BMC Cancer
188 rdf:type schema:Periodical
189 sg:person.01030427112.43 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
190 schema:familyName Ungerechts
191 schema:givenName Guy
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030427112.43
193 rdf:type schema:Person
194 sg:person.01040326116.86 schema:affiliation N588b26f6ee1e47129539ee9316987bb2
195 schema:familyName Halama
196 schema:givenName Niels
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040326116.86
198 rdf:type schema:Person
199 sg:person.01057707502.40 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
200 schema:familyName Sedlaczek
201 schema:givenName Oliver
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057707502.40
203 rdf:type schema:Person
204 sg:person.01061037342.51 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
205 schema:familyName Rommelaere
206 schema:givenName Jean
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061037342.51
208 rdf:type schema:Person
209 sg:person.01100645057.61 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
210 schema:familyName Kieser
211 schema:givenName Meinhard
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100645057.61
213 rdf:type schema:Person
214 sg:person.011060761054.89 schema:affiliation https://www.grid.ac/institutes/grid.476663.6
215 schema:familyName Krebs
216 schema:givenName Ottheinz
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060761054.89
218 rdf:type schema:Person
219 sg:person.01130362500.35 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
220 schema:familyName Lehmann
221 schema:givenName Monika
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130362500.35
223 rdf:type schema:Person
224 sg:person.01143116022.75 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
225 schema:familyName Schöning
226 schema:givenName Tilman
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143116022.75
228 rdf:type schema:Person
229 sg:person.01145603317.47 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
230 schema:familyName Leuchs
231 schema:givenName Barbara
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145603317.47
233 rdf:type schema:Person
234 sg:person.01147032652.28 schema:affiliation https://www.grid.ac/institutes/grid.476663.6
235 schema:familyName Dahm
236 schema:givenName Michael
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147032652.28
238 rdf:type schema:Person
239 sg:person.01240304374.43 schema:affiliation N1484249b67154b53a6d73b75be531a99
240 schema:familyName Daniel
241 schema:givenName Volker
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240304374.43
243 rdf:type schema:Person
244 sg:person.01257757651.52 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
245 schema:familyName Angelova
246 schema:givenName Assia
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257757651.52
248 rdf:type schema:Person
249 sg:person.0605770352.37 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
250 schema:familyName Hajda
251 schema:givenName Jacek
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605770352.37
253 rdf:type schema:Person
254 sg:person.0642002247.65 schema:affiliation https://www.grid.ac/institutes/grid.476663.6
255 schema:familyName Huber
256 schema:givenName Bernard
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642002247.65
258 rdf:type schema:Person
259 sg:person.0642700650.98 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
260 schema:familyName Stenzinger
261 schema:givenName Albrecht
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642700650.98
263 rdf:type schema:Person
264 sg:person.0644466327.44 schema:affiliation https://www.grid.ac/institutes/grid.419810.5
265 schema:familyName Geletneky
266 schema:givenName Karsten
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644466327.44
268 rdf:type schema:Person
269 sg:person.0704340157.73 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
270 schema:familyName Engeland
271 schema:givenName Christine E.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704340157.73
273 rdf:type schema:Person
274 sg:person.0726633256.58 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
275 schema:familyName Jäger
276 schema:givenName Dirk
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726633256.58
278 rdf:type schema:Person
279 sg:person.0735442654.05 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
280 schema:familyName Springfeld
281 schema:givenName Christoph
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735442654.05
283 rdf:type schema:Person
284 sg:pub.10.1007/978-1-4471-6458-6_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039666242
285 https://doi.org/10.1007/978-1-4471-6458-6_5
286 rdf:type schema:CreativeWork
287 sg:pub.10.1016/j.gassur.2005.06.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037816799
288 https://doi.org/10.1016/j.gassur.2005.06.024
289 rdf:type schema:CreativeWork
290 sg:pub.10.1038/bjc.2015.328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010315581
291 https://doi.org/10.1038/bjc.2015.328
292 rdf:type schema:CreativeWork
293 sg:pub.10.1038/cgt.2010.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045602992
294 https://doi.org/10.1038/cgt.2010.65
295 rdf:type schema:CreativeWork
296 sg:pub.10.1186/1471-2407-12-99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031811534
297 https://doi.org/10.1186/1471-2407-12-99
298 rdf:type schema:CreativeWork
299 sg:pub.10.1186/1479-5876-5-60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049027309
300 https://doi.org/10.1186/1479-5876-5-60
301 rdf:type schema:CreativeWork
302 https://app.dimensions.ai/details/publication/pub.1075234158 schema:CreativeWork
303 https://app.dimensions.ai/details/publication/pub.1076431462 schema:CreativeWork
304 https://app.dimensions.ai/details/publication/pub.1078931140 schema:CreativeWork
305 https://app.dimensions.ai/details/publication/pub.1079004265 schema:CreativeWork
306 https://doi.org/10.1002/cncr.22852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009856216
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1016/0166-0934(91)90024-t schema:sameAs https://app.dimensions.ai/details/publication/pub.1021418357
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1016/j.canlet.2014.10.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032696037
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/j.ejca.2012.12.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036026674
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/j.ymthe.2004.07.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033281430
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1016/s0140-6736(14)61396-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046101168
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1038/mt.2008.29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037260104
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1038/mt.2014.194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018359073
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1056/nejmoa1011923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022967950
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1056/nejmoa1304369 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034846582
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1080/2162402x.2015.1115641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047118395
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1093/annonc/mdu138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046778815
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1093/jnci/76.6.1177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079761076
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1111/j.1439-0450.2005.00877.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044102158
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1126/science.145.3631.510 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062483166
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1128/jvi.03688-13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016708328
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1158/0008-5472.can-14-2533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053419719
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1158/1078-0432.ccr-08-1088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034525025
341 rdf:type schema:CreativeWork
342 https://doi.org/10.1158/2159-8290.cd-11-0242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035264688
343 rdf:type schema:CreativeWork
344 https://doi.org/10.1200/jco.2009.25.7550 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000628191
345 rdf:type schema:CreativeWork
346 https://doi.org/10.3892/ijo.27.4.901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071515841
347 rdf:type schema:CreativeWork
348 https://doi.org/10.6092/1590-8577/2028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078811321
349 rdf:type schema:CreativeWork
350 https://www.grid.ac/institutes/grid.419810.5 schema:alternateName Klinikum Darmstadt
351 schema:name Department of Neurosurgery, Klinikum Darmstadt, Grafenstraße 9, 64283, Darmstadt, Germany
352 rdf:type schema:Organization
353 https://www.grid.ac/institutes/grid.476663.6 schema:alternateName ORYX (Germany)
354 schema:name Oryx GmbH & Co KG, Marktplatz 1, 85598, Baldham, Germany
355 rdf:type schema:Organization
356 https://www.grid.ac/institutes/grid.5253.1 schema:alternateName University Hospital Heidelberg
357 schema:name Central Pharmacy, University Hospital Heidelberg, Im Neuenheimer Feld 670, 69120, Heidelberg, Germany
358 Coordination Centre for Clinical Trials, University Hospital Heidelberg, Marsilius-Arkaden, Tower West, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany
359 Department of Medical Oncology, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
360 Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany
361 Institute of Medical Biometry and Informatics, University Hospital Heidelberg, Marsilius-Arkaden, Tower West, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany
362 rdf:type schema:Organization
363 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
364 schema:name Department of Applied Tumor Virology, German Cancer Research Center, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany
365 Department of Radiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany
366 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...